Cite
HARVARD Citation
Lee, S. et al. (2016). Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs. Medicine. 96 (1), pp. e5321-. [Online].